Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1242.00
-3.50 (-0.28%)
< Home < Back

Dr. Reddy's gets 2 observations from USFDA for Hyderabad Plant

Date: 28-02-2020

US Food and Drug Administration (USFDA) has completed the audit of Dr. Reddy's Laboratories’ Formulations Manufacturing Plant - 3 at Bachupally, Hyderabad. The company has been issued a Form 483 with 2 observations. The company will address them comprehensively within the stipulated timeline.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.